While having a career as a flight attendant allows individuals to travel the globe, exposure to carcinogens and frequent disruptions in circadian rhythms may increase cancer prevalence in these individuals, according to recent research published in the journal Environmental Health.
I'm learning to expect scanxiety, and that helped keep it at bay.
Adversity early on in life and increased stress levels could impact ovarian cancer outcomes – even if these instances happen before a woman is diagnosed, according to a recent article published in the journal Cancer.
A look at how one cancer survivor has witnessed life-changing medical advancements over the years.
While there has been no hard evidence that exercise can improve survival in patients with cancer, it can boost patients' mood and how they feel.
The American Cancer Society issued an updated guideline recommendation that now calls for screening to begin at age 45 for individuals at average risk for colorectal cancer.
Understanding one’s biomarkers, such as microsatellite stable (MSS) or instable (MSI) status in tumors, is key in understanding how a patient with colorectal cancer may be treated.
I laughed after I put my soiled laundry in the wastepaper bin in my bathroom instead of the laundry hamper. When I told my oncologist, she didn’t think it was funny at all.
When my mom got cancer, the last thing on my mind was my own health, but she had the foresight and the care to get a genetic test so that her kids could live long and healthy lives. Today I am grateful for my mom, my whole family and the magic of science.
Take a look at the top five CURE stories of June 2018 in this video.
The Food and Drug Administration (FDA) granted a priority review to Keytruda (pembrolizumab) in combination with chemotherapy as a first-line treatment for metastatic squamous non-small cell lung cancer (NSCLC), regardless of PD-L1 expression, according to Merck, the manufacturer of the anti-PD-1 agent.
Is it too much to want to feel like myself again after cancer?
Five techniques to help you when "wait and see" is the only option
PARP inhibitors continue to impress in the ovarian cancer space, as findings from the recent phase 3 SOLO-1 trial showed that Lynparza (olaparib) showed clinically-meaningful improvement in progression-free survival (PFS) when used in the first-line maintenance setting.
Because little is known about the effect of patients' sex on the efficacy of immune checkpoint inhibitors as cancer treatments, the researchers performed a systematic review and meta-analysis to determine the heterogeneity of immune checkpoint inhibitor efficacy between men and women.
Sometimes it pays to play the cancer card.
There are many signs and symptoms of breast cancer, although some of them aren't very well known. Early detection can help prevent more serious problems. Learn more about how to recognize and protect yourself.
What are the different types of immunotherapy and, importantly, what are fellow patients saying about them?
Moving from shock to action is hard, but it's critical to surviving cancer
At the end of life, patients and physicians both have their own goals when it comes to care and treatment; however, researchers from Case Western Reserve University and Flatiron Health have found that those goals are sometimes at odds with one another.
At the GI Cancer Patient Summit, a panel of caregivers drew upon personal experience to offer advice and discuss what more can be done for individuals in this role of the cancer journey.
Cancer can give writers a special edge.
We spoke with veteran journalist Neil Canavan about his book, A Cure Within: Scientists Unleashing the Immune System to Kill Cancer.
The FDA has approved the combination of the BRAF inhibitor Braftovi (encorafenib) and the MEK inhibitor Mektovi (binimetinib) for the treatment of patients with BRAF-mutant unresectable or metastatic melanoma, as detected by an FDA-approved test.
The Food and Drug Administration (FDA) has granted a priority review to a new drug application (NDA) for glasdegib to treat patients with previously untreated acute myeloid leukemia (AML) in combination with low-dose cytarabine (LDAC), which is a type of chemotherapy, according to Pfizer, the manufacturer of the drug.
As we survive cancer, people often turn to us for advice. Listening mindfully as we also share personal tips can help others in their cancer journeys. The list of tips can only grow from survivor to survivor. What do you have to share?
These discussions should include information about the cancer itself, as well as treatment options, side effects, prognosis, and most importantly, the patient’s values.
Four ways of helping cancer survivors deal with anxiety and depression.
Checkpoint inhibitors — immunotherapy drugs that are improving the treatment landscape for many patients across the spectrum of cancers — are relatively new. The science involved in finding and treating the patients most likely to respond to these drugs — without overlooking any or treating those who won’t benefit — is even newer.
A no-brainer bill about student loans for young adult cancer patients that I spent a day advocating for. You can help - read to the end!
